Not currently recruiting at University of California Health
A Study of PRT3789 in Participants With Select Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at UCLA
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients at some sites,
but this study is not currently recruiting here - Start Date
- Completion Date
- (estimated)
- Sponsor
- Prelude Therapeutics
- ID
- NCT05639751
- Phase
- Phase 1 research study
- Study Type
- Interventional
- Participants
- Expecting 86 study participants
- Last Updated